Dr. Agarwal's Health Care IPO
Dr. Agarwal's Health Care Limited (AGARWALEYE) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 04 February 2025.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain -1.8% (likely range -10% to +8%), day's high +6.2%, chance of a gain 33%. Actual: 0.0% at the open, +2.7% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 1,45,19,200 | 6,73,61,280 | 4.64x | |
| NII (HNI) total | 1,08,89,400 | 43,07,310 | 0.40x | |
| Big NII (above ₹10 lakh) | 72,59,600 | 22,85,955 | 0.31x | |
| Small NII (₹2-10 lakh) | 36,29,800 | 20,21,355 | 0.56x | |
| Retail | 2,54,08,599 | 1,05,40,285 | 0.41x | |
| Employees | 15,79,399 | 4,25,565 | 0.27x | |
| Shareholders | 11,29,574 | 5,83,940 | 0.52x | |
| Total | 5,35,26,172 | 8,32,18,380 | 1.55x |
Bids on NSE and BSE together, as published by NSE, as of 31 Jan 2025, 07:00 PM. Shares offered exclude the anchor portion. 12% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Dr. Agarwal's Health Care's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| Gland PharmaNov 2020 | 6.40x | 0.51x | 0.24x | 2.06x | ₹6,480 Cr | +14.0% | +23.3% |
| DelhiveryMay 2022 | 2.66x | 0.30x | 0.57x | 1.63x | ₹5,519 Cr | +1.7% | +16.8% |
| Varun BeveragesOct 2016 | 4.94x | 0.42x | 0.82x | 1.86x | ₹1,112 Cr | -3.4% | +6.0% |
| Aavas FinanciersSep 2018 | 2.77x | 0.26x | 0.25x | 0.97x | ₹1,734 Cr | -8.7% | -4.1% |
| Chalet HotelsJan 2019 | 4.66x | 1.10x | 0.03x | 1.57x | ₹1,649 Cr | +5.0% | +7.1% |
| Lemon Tree HotelsMar 2018 | 3.89x | 0.12x | 0.12x | 1.19x | ₹1,039 Cr | +10.0% | +32.0% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| Kotak Mahindra Capital Company | 83 | +20.8% | 76% |
| Morgan Stanley India Company | 24 | +13.9% | 67% |
| Jefferies India | 26 | +19.5% | 81% |
| Motilal Oswal Investment Advisors | 47 | +15.0% | 72% |
Offer documents (NSE)
Frequently asked
What is the Dr. Agarwal's Health Care IPO price band and lot size? ₹382–402 per share, with a lot of 35 shares, so the smallest retail bid is ₹14,070.
How many times has it been subscribed? 1.55x overall: QIB 4.64x, NII 0.40x, retail 0.41x, employees 0.27x.
How did it list? It opened at ₹402, +0.0% against the issue price of ₹402, and closed its first day -0.1%.
